发明名称 Method and Implantable System for Blood-Glucose Concentration Monitoring Using Parallel Methodologies
摘要 In an implantable medical device for monitoring glucose concentration in the blood, a blood-glucose concentration analysis is performed using correlations of blood-glucose concentration with measures of metabolic oxygen consumption including oxymetric, and/or temperature. Analysis of electrocardiographic data is used in a parallel method to detect and/or confirm the onset and/or existence and/or extent of hypoglycemia and/or hyperglycemia. Blood-glucose concentration calculation is enhanced by using the combination of the oxygen metabolism analysis and electrocardiographic analysis.
申请公布号 US2014221771(A1) 申请公布日期 2014.08.07
申请号 US201314101942 申请日期 2013.12.10
申请人 Pacesetter, Inc. 发明人 Wenzel Brian Jeffrey;Farazi Taraneh Ghaffari;Park Euljoon;Falkenberg Eric;Benser Michael E.
分类号 A61B5/145;A61B5/0452;A61B5/00;A61B5/0205;A61B5/0428;A61B5/04 主分类号 A61B5/145
代理机构 代理人
主权项 1. An implantable system for monitoring blood-glucose concentration in a patient, comprising: an EGM sensing circuit that senses one or more cardiac electrical signal and generates EGM data indicative of the one or more cardiac electrical signal; an EGM analysis unit that receives the EGM data from the EGM sensing circuit and generates a first metric of blood-glucose concentration using the EGM data; an oxygen metabolism sensor that monitors one or more property of oxygen metabolism and generates oxygen metabolism data indicative of the one or more property of oxygen metabolism; an oxygen metabolism analysis unit that receives the oxygen metabolism data from the oxygen metabolism sensor and generates a second metric of blood-glucose concentration using the oxygen metabolism data; and a blood-glucose concentration analysis unit that receives the first metric of blood-glucose concentration and the second metric of blood-glucose concentration and generates an enhanced metric of blood-glucose concentration.
地址 Sunnyvale CA US